GC Genome Corporation (KOSDAQ:340450)
7,570.00
+90.00 (1.20%)
Apr 14, 2026, 2:25 PM KST
-47.06% (1Y)
| Market Cap | 176.91B |
| Revenue (ttm) | 31.53B +21.8% |
| Net Income | 4.04B |
| EPS | 185.00 |
| Shares Out | 23.65M |
| PE Ratio | 40.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 83,111 |
| Average Volume | 189,862 |
| Open | 7,510.00 |
| Previous Close | 7,480.00 |
| Day's Range | 7,510.00 - 7,750.00 |
| 52-Week Range | 6,200.00 - 15,180.00 |
| Beta | n/a |
| RSI | 47.87 |
| Earnings Date | Apr 10, 2026 |